BRAF and neoplasm: Baseline upregulation of several RTKs, RAS, p-CRAF and p-p90rsk were also seen in three BRAFV600E HGG tumours (including one paediatric and one adolescent sample) collected following relapse after BRAF inhibitor treatment (40).